Cargando…

Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer

BACKGROUND: The enhancer of zeste-homolog 2 (EZH2) is involved in cancer development through gene silencing by trimethylation of lysine 27 of histone 3 (H3K27me3). The C/C genotype for the EZH2 rs3757441 single-nucleotide polymorphism (SNP) is linked with poor prognosis in metastatic colorectal canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fornaro, Lorenzo, Faviana, Pinuccia, De Gregorio, Veronica, Vivaldi, Caterina, Paolicchi, Elisa, Masi, Gianluca, Loupakis, Fotios, Sensi, Elisa, Lupi, Cristiana, Fontanini, Gabriella, Wang, Yuzhuo, Danesi, Romano, Falcone, Alfredo, Crea, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640238/ https://www.ncbi.nlm.nih.gov/pubmed/26553291 http://dx.doi.org/10.1186/s12885-015-1889-2

Ejemplares similares

KRAS and BRAF genotyping of synchronous colorectal carcinomas
por: GIANNINI, RICCARDO, et al.
Publicado: (2014)

Feasibility of BRCA1/2 Testing of Formalin-Fixed and Paraffin-Embedded Pancreatic Tumor Samples: A Consecutive Clinical Series
por: Bruno, Rossella, et al.
Publicado: (2021)

A single nucleotide polymorphism in EZH2 predicts overall survival rate in patients with cholangiocarcinoma
por: PAOLICCHI, ELISA, et al.
Publicado: (2013)

Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation
por: Fornaro, Lorenzo, et al.
Publicado: (2017)

EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition
por: Rotella, Virginia, et al.
Publicado: (2014)

Are Renal Cell Carcinoma with Fibromyomatous Stroma (RCC-FMS) and Thyroid-like Follicular Carcinoma of the Kidney (TLFCK) Really Independent Variants?
por: Stanca, Stefano, et al.
Publicado: (2022)

Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 months
por: Marconcini, Riccardo, et al.
Publicado: (2017)

Intraductal prostate cancer: An aggressive subset of prostate cancers? Immunophenotypic evaluation
por: Faviana, Pinuccia, et al.
Publicado: (2022)

Multi-Dimensional Scaling Analysis of Key Regulatory Genes in Prostate Cancer Using the TCGA Database
por: Boldrini, Laura, et al.
Publicado: (2021)

Comment on: ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'
por: Vivaldi, Caterina, et al.
Publicado: (2016)

Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer
por: Del Re, Marzia, et al.
Publicado: (2017)

Primary small cell carcinoma of the ureter: Case report and review of the literature
por: Farci, Fabiola, et al.
Publicado: (2018)

The long and short non-coding RNAs modulating EZH2 signaling in cancer
por: Mirzaei, Sepideh, et al.
Publicado: (2022)

BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection
por: Schirripa, M, et al.
Publicado: (2015)

Unusual Case of Pancreatic Adenocarcinoma with Bladder Metastasis
por: Arcovito, Giorgia, et al.
Publicado: (2020)

Robotically assisted removal of pelvic splenosis fifty-six years after splenectomy: A case report
por: Tognarelli, Alessio, et al.
Publicado: (2021)

Autologous fascial slings remain viable at long-term follow-up: a post cystectomy case report
por: Durante, Jacopo, et al.
Publicado: (2021)

Correction: The long and short non-coding RNAs modulating EZH2 signaling in cancer
por: Mirzaei, Sepideh, et al.
Publicado: (2022)

A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer
por: Vasile, E, et al.
Publicado: (2009)

A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients
por: Allegrini, G, et al.
Publicado: (2008)

Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution
por: Cesario, Silvia, et al.
Publicado: (2023)

Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer
por: Loupakis, F, et al.
Publicado: (2011)

Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen?
por: Faviana, Pinuccia, et al.
Publicado: (2021)

Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers
por: Allegrini, Giacomo, et al.
Publicado: (2012)

The rs2071559 AA VEGFR-2 Genotype Frequency Is Significantly Lower in Neovascular Age-Related Macular Degeneration Patients
por: Lazzeri, Stefano, et al.
Publicado: (2012)

Proposal for a New Diagnostic Histopathological Approach in the Evaluation of Ki-67 in GEP-NETs
por: Faviana, Pinuccia, et al.
Publicado: (2022)

Tumor Progression from a Fibroblast Activation Protein Perspective: Novel Diagnostic and Therapeutic Scenarios for Colorectal Cancer
por: Rossetti, Martina, et al.
Publicado: (2023)

The role of EZH1 and EZH2 in development and cancer
por: Lee, Soo Hyun, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Esophageal Cancers: Are We Finally Finding the Right Path in the Mist?
por: Vivaldi, Caterina, et al.
Publicado: (2020)

Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
por: Graziano, F, et al.
Publicado: (2008)

Cancer Immunotherapy and Identification of Prognostic and Predictive Biomarkers
por: Criscitiello, Carmen, et al.
Publicado: (2018)

Response to erlotinib in a patient with lung adenocarcinoma harbouring the EML4-ALK translocation: A case report
por: ALÌ, GRETA, et al.
Publicado: (2015)

A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma
por: Fontanini, G, et al.
Publicado: (2002)

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
por: Loupakis, F, et al.
Publicado: (2009)

Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis
por: Scartozzi, Mario, et al.
Publicado: (2009)

dDAVP Downregulates the AQP3-Mediated Glycerol Transport via V1aR in Human Colon HCT8 Cells
por: Centrone, Mariangela, et al.
Publicado: (2022)

Hurrying up but not rushing, acting and not reacting, good sense and not common sense: Open thoughts and reasonable doubts on COVID-19 vaccination strategies in cancer patients
por: Loupakis, Fotios, et al.
Publicado: (2021)

Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer
por: Fornaro, Lorenzo, et al.
Publicado: (2019)

Primary Resistance to Immunotherapy-Based Regimens in First Line Hepatocellular Carcinoma: Perspectives on Jumping the Hurdle
por: Salani, Francesca, et al.
Publicado: (2022)

Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors
por: Shinohara, Haruka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pesq0kqt45kacn44qmjoprthk9